Buscar
Mostrando ítems 1-10 de 78
A third generation regimen VACOP-B with or without adjuvant radiotherapy for aggressive localized non-Hodgkin's lymphoma: report from the Italian Non-Hodgkin's Lymphoma Co-operative Study Group
(Associação Brasileira de Divulgação Científica, 2004)
Proliferating cell nuclear antigen (PCNA) in non-Hodgkin's lymphomas: Correlation with working formulation and Kiel classification in formalin-fixed paraffin-embedded material
(1996-03-13)
PCNA is a 36-KD proliferating cell nuclear antigen associated with the cell cycle. The immunocytochemical detection of PCNA represents a useful tool for the study of tumor proliferation activity. This study documents the ...
Proliferating cell nuclear antigen (PCNA) in non-Hodgkin's lymphomas: Correlation with working formulation and Kiel classification in formalin-fixed paraffin-embedded material
(1996-03-13)
PCNA is a 36-KD proliferating cell nuclear antigen associated with the cell cycle. The immunocytochemical detection of PCNA represents a useful tool for the study of tumor proliferation activity. This study documents the ...
Blastoid variant of mantle cell lymphoma in palatine tonsil
(2021-11-01)
Blastoid variant of mantle cell lymphoma (MCL) is an aggressive and extremely rare malignancy. MCL may be diagnosed in lymph nodes and/or extranodal sites exhibiting a poor prognosis. MCL with primary presentation in ...
Linfoma semelhante a Hodgkin com apresentação nodal em felino
(Universidade Federal de Santa MariaBrasilUFSMCentro de Ciências Rurais, 2022-03-22)
Lymphoma can be divided, considering histological aspects, into Hodgkin's and non-Hodgkin's lymphoma.While non-Hodgkin's lymphoma has a more aggressive biological behavior, Hodgkin's lymphoma has a less aggressive biological ...
O transplante de células-tronco hematopoéticas no tratamento dos linfomas não HodgkinHematopoietic stem cell transplantation for non-Hodgkin lymphomas
(Associação Brasileira de Hematologia e Hemoterapia e daSociedade Brasileira de Transplante de Medula Óssea, 2010)
A third generation regimen VACOP-B with or without adjuvant radiotherapy for aggressive localized non-Hodgkin's lymphoma - Report from the Italian Non-Hodgkin's Lymphoma Co-operative Study Group
(Assoc Bras Divulg CientificaSao PauloBrasil, 2004)
Clinical significance of metabolism-related biomarkers in non-Hodgkin lymphoma-MCT1 as potential target in diffuse large B cell lymphoma
(Springer, 2019-06-01)
PurposeIncreased glycolytic activity with accumulation of extracellular lactate is regarded as a hallmark of cancer. In lymphomas, FDG-PET has undeniable diagnostic and prognostic value, corroborating that these tumours ...